• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines

Professional Introduction to 2-Fluoroquinoline (CAS No. 580-21-2)

2-Fluoroquinoline, identified by the chemical compound code CAS No. 580-21-2, is a fluorinated derivative of quinoline that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound serves as a versatile scaffold for the development of various therapeutic agents, particularly those targeting infectious diseases and cancer. The introduction of a fluorine atom at the 2-position of the quinoline ring enhances its pharmacological properties, making it a valuable intermediate in synthetic chemistry.

The quinoline scaffold itself has a long history in medicinal chemistry, with numerous derivatives exhibiting antimicrobial, antimalarial, and anticancer activities. The introduction of fluorine at the 2-position modifies the electronic and steric properties of the molecule, influencing its binding affinity to biological targets. This modification has been shown to improve metabolic stability and bioavailability, which are critical factors in drug design.

In recent years, 2-Fluoroquinoline has been extensively studied for its potential applications in the treatment of resistant bacterial infections. Fluoroquinolones, a class of antibiotics derived from quinolone compounds, have been widely used due to their broad-spectrum activity against Gram-negative and Gram-positive bacteria. The fluorine atom in 2-Fluoroquinoline enhances the molecule's ability to interact with bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial replication and transcription.

Recent research has highlighted the structural modifications of 2-Fluoroquinoline that enhance its efficacy against multidrug-resistant bacteria. For instance, studies have demonstrated that incorporating additional substituents at the 3- and 4-positions of the quinoline ring can further improve binding affinity to bacterial enzymes. These modifications have led to the development of novel fluoroquinolone analogs with enhanced potency and reduced side effects.

Beyond its applications in antibiotics, 2-Fluoroquinoline has also shown promise in oncology research. The fluorine atom's ability to influence electron distribution in the molecule makes it an attractive candidate for developing kinase inhibitors. Kinases are enzymes involved in cell signaling pathways that are often dysregulated in cancer cells. By targeting these kinases, researchers aim to develop therapies that can selectively inhibit tumor growth while minimizing toxicity to healthy cells.

A notable study published in [year] investigated the use of 2-Fluoroquinoline derivatives as inhibitors of tyrosine kinases, which play a crucial role in cancer cell proliferation and survival. The study revealed that certain fluorinated quinolines exhibit potent inhibitory activity against several tyrosine kinases, including EGFR (epidermal growth factor receptor) and HER2 (human epidermal growth factor receptor 2). These findings suggest that 2-Fluoroquinoline derivatives could be developed into novel anticancer agents.

The synthesis of 2-Fluoroquinoline involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include Friedel-Crafts acylation followed by fluorination and cyclization steps. Advanced techniques such as transition metal-catalyzed cross-coupling reactions have also been employed to introduce fluorine atoms at specific positions on the quinoline ring.

In conclusion, 2-Fluoroquinoline (CAS No. 580-21-2) is a structurally significant compound with broad applications in pharmaceutical research. Its role in developing novel antibiotics and anticancer agents underscores its importance in medicinal chemistry. As research continues to uncover new derivatives and applications, 2-Fluoroquinoline is poised to remain a cornerstone in therapeutic drug development.

• 84048-63-5(Pyridine, 2,6-difluoro-, radical ion(1+) (9CI))
• 874634-06-7(Quinoline, fluoro-)
• 53339-31-4(Pyridine, fluoro-)
• 396-29-2(3-Fluoroisoquinoline)
• 394-65-0(1-fluoro-Isoquinoline)
• 1082041-03-9(6-fluoro-1h-pyrrolo[3,2-c]pyridine)
• 1513-65-1(2,6-Difluoropyridine)
• 372-48-5(2-Fluoropyridine)
• 771-37-9(2-fluoro-4-methyl-Quinoline)
• 163275-69-2(Benzo[h]quinoline, 2-fluoro-)